Gene · 4171
Papers3,775
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,775
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Voluntary Exercise Attenuates Tumor Growth in a Preclinical Model of Castration-Resistant Prostate Cancer. | Med Sci Sports Exerc | 2025 | 40173332 | PubTator, text mining | PubMed |
| NF-κB signaling directs a program of transient amplifications at innate immune response genes. | bioRxiv | 2025 | 40161744 | PubTator, text mining | PubMed |
| Effects of CDC45 mutations on DNA replication and genome stability. | Biochim Biophys Acta Mol Cell Res | 2025 | 40139510 | PubTator, text mining | PubMed |
| Refining prognostic stratification of atypical meningiomas: significance of chromosome 1p deletion and brain invasion. | Acta Neuropathol Commun | 2025 | 40050905 | PubTator, text mining | PubMed |
| The EZH2/MCM Complex/hTERT axis facilitates hepatocellular carcinoma progression by inhibiting cellular senescence. | Mech Ageing Dev | 2025 | 39933657 | PubTator, text mining | PubMed |
| Comparative transcriptomic analysis of primary endometrial cancer and bone metastatic cancer: metastasis-associated genes and abnormal cell cycle regulation. | Discov Oncol | 2025 | 39893325 | PubTator, text mining | PubMed |
| Unidirectional MCM translocation away from ORC drives origin licensing. | Nat Commun | 2025 | 39824870 | PubTator, text mining | PubMed |
| Clinical significance and pro-oncogenic function of DBF4 in clear cell renal cell carcinoma. | BMC Urol | 2025 | 39815239 | PubTator, text mining | PubMed |
| TanGIBLE: A selective probe for evaluating hydrophobicity-exposed defective proteins in live cells. | J Cell Biol | 2025 | 39812643 | PubTator, text mining | PubMed |
| Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer. | Breast Cancer (Dove Med Press) | 2025 | 39811603 | PubTator, text mining | PubMed |
| Epigenetic drug screening identifies enzyme inhibitors A-196 and TMP-269 as novel regulators of sprouting angiogenesis. | Sci Rep | 2025 | 39794417 | PubTator, text mining | PubMed |
| Cell cycle progression of under-replicated cells. | Nucleic Acids Res | 2025 | 39778868 | PubTator, text mining | PubMed |
| MCM2-7 ring closure involves the Mcm5 C-terminus and triggers Mcm4 ATP hydrolysis. | Nat Commun | 2025 | 39747125 | PubTator, text mining | PubMed |
| Evaluation of BUBR1, MCM2, and GMNN as oral cancer biomarkers. | Eur J Cancer Prev | 2025 | 39480819 | PubTator, text mining | PubMed |
| Quinic acid contributes to neurogenesis: Targeting Notch pathway a key player in hippocampus. | Brain Res | 2025 | 39442647 | PubTator, text mining | PubMed |
| Investigating the Mechanisms of Anti-tumoral Effect of Combination Therapy of Calcitriol and Sodium Pentaborate Pentahydrate on HepG2 Hepatocellular Carcinoma Cells. | Biol Trace Elem Res | 2025 | 39441231 | PubTator, text mining | PubMed |
| Integrating Mcm-2 and Ki-67 immunohistochemistry with clinico-pathologic parameters for enhanced prognostic accuracy in oral verrucous lesions. | J Stomatol Oral Maxillofac Surg | 2025 | 39244032 | PubTator, text mining | PubMed |
| Network-base approaches to identify therapeutic biomarkers in hepatocellular carcinoma and search for drug hunting utilizing molecular dynamics simulations. | J Biomol Struct Dyn | 2025 | 38486461 | PubTator, text mining | PubMed |
| Expression of minichromosome maintenance proteins in the exfoliated cells supplement sputum cytology in the diagnosis of lung cancer. | Cytojournal | 2024 | 39927285 | PubTator, text mining | PubMed |
| FUS and METTL3 collaborate to regulate RNA maturation, preventing unfolded protein response and promoting gastric cancer progression. | Clin Exp Med | 2024 | 39708203 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4171/papers?page=6